The global pharmaceutical industry is evolving rapidly. As demand for high-quality medicines increases across emerging and developed markets a like, global pharma brands are under constant pressure to reduce costs, maintain quality, and scale production efficiently. For many, the answer lies in partnering with a trusted contract manufacturer – and increasingly, that partner is based in India.
In this blog, we explore why India has become the preferred destination for pharmaceutical contract manufacturing, and what the WHO-GMP advantage really means for global buyers.
What Is Contract Pharmaceutical Manufacturing?
Contract pharmaceutical manufacturing is an arrangement where a company outsources the production of its medicines or formulations to a third-party manufacturer. The contract manufacturer handles production, quality control, packaging, and in many cases, regulatory documentation – while the brand company retains ownership of the product.
This model allows global pharma companies to:
- Expand their product range without investing in new production facilities
- Enter new markets faster by leveraging an established manufacturer’s regulatory approvals
- Reduce capital expenditure while maintaining product quality
- Access specialised manufacturing capabilities such as injectables, inhalers, or effervescent formulations
India’s contract manufacturing sector has grown significantly over the past two decades, with facilities increasingly meeting the highest international regulatory standards.
The Consequences of Choosing the Wrong Supplier
Selecting the wrong contract manufacturing partner can have serious and far-reaching consequences. Poor quality control can result in substandard or contaminated batches, putting patients at risk and exposing your business to product recalls, regulatory penalties, and reputational damage. A supplier without the right certifications can cause your shipments to be rejected at customs, leading to costly delays and supply gaps. Inconsistent production timelines can disrupt your entire distribution network, leaving markets understocked. In regulated markets, a single compliance failure can result in your products being blacklisted by health authorities – a setback that can take years to recover from. Choosing the right manufacturing partner from the outset is not just a procurement decision – it is a business-critical one.
India’s Position in Global Pharma Manufacturing
India is the world’s largest supplier of generic medicines, contributing nearly 20% of global generic drug exports by volume. The country supplies medicines to over 200 nations, including highly regulated markets such as the United States, the United Kingdom, the European Union, and Africa.
This dominance is not accidental. It is built on decades of investment in pharmaceutical infrastructure, scientific talent, regulatory expertise, and a culture of quality-driven manufacturing.
For global pharma companies looking to outsource production, India offers something rare – a combination of scale, affordability, and regulatory credibility that is difficult to find anywhere else in the world.
The WHO-GMP Advantage – Why It Matters
When evaluating a contract manufacturing partner, WHO-GMP certification is one of the most critical criteria for global buyers.
WHO-GMP stands for World Health Organisation Good Manufacturing Practice. It is an internationally recognised quality standard that governs how pharmaceutical products are manufactured, tested, and controlled. A WHO-GMP certified facility has demonstrated that it meets stringent requirements across:
A WHO-GMP certified facility has demonstrated that it meets stringent requirements across:
- Manufacturing Environment — cleanrooms, controlled temperature and humidity, sterile production areas designed to prevent contamination at every stage of production
- Quality Control — rigorous testing of raw materials, in-process checks, and finished product release to ensure every batch meets defined specifications
- Documentation — complete traceability of every batch produced, from raw material receipt to final product dispatch
- Personnel — trained and qualified staff at every level of production, with defined roles and responsibilities
- Equipment — validated, calibrated, and regularly maintained machinery to ensure consistent and reliable manufacturing output
- Standard Operating Procedures (SOPs) — comprehensive, documented SOPs governing every manufacturing process, cleaning procedure, quality check, and deviation handling protocol to ensure consistency, compliance, and full regulatory traceability across all operations regularly maintained machinery
For international buyers – whether government procurement agencies, hospital groups, or private pharma companies – WHO-GMP certification is strongly preferred by regulatory authorities for importation into regulated markets, including most African nations, Southeast Asia, and the Gulf region.
Partnering with a WHO-GMP certified Indian manufacturer means faster regulatory approvals, easier market entry, and the confidence that every batch meets international quality benchmarks.
Why Kilitch Drugs Is the Right Contract Manufacturing Partner
Kilitch Drugs (India) Ltd. has been manufacturing pharmaceutical products since 1978, with nearly five decades of experience in producing and supplying medicines to markets across more than 49+ countries.
Our WHO-GMP certified manufacturing facility produces a comprehensive range of formulations including:
- Liquid Injectables — antibiotics, anaesthetics, vitamins and critical care injections
- Effervescent Formulations — antacids, multivitamins, paracetamol and nutritional supplements in fast-dissolving effervescent tablets and granules
- Metered Dose Inhalers — for asthma and COPD management
- Prefilled Syringes — for hospital and acute care settings
- Nutraceuticals — collagen shots, herbal lozenges and multivitamin supplements
- OTC Range — effervescent tablets, sprays and granules
Beyond manufacturing capability, Kilitch offers end-to-end contract manufacturing services including technology transfer, formulation development, regulatory documentation support, and global supply chain management. Our team works closely with each partner to ensure seamless product launch and consistent supply.
The Cost Advantage Without Compromising Quality
One of the most compelling reasons global brands choose India is cost efficiency. Manufacturing costs in India are significantly lower than in Western markets without any compromise on quality standards.
This cost advantage stems from lower labour costs, abundant availability of raw materials, a robust API (Active Pharmaceutical Ingredient) manufacturing ecosystem, and established supply chain infrastructure. For global buyers, this translates into better margins, more competitive pricing in end markets, and the ability to scale volumes without proportional cost increases.
Conclusion
India’s pharmaceutical contract manufacturing sector represents a unique convergence of quality, capacity, regulatory credibility, and cost competitiveness. For global pharma brands looking for a reliable manufacturing partner, the combination of WHO-GMP certified facilities, decades of export experience, and a full spectrum of manufacturing capabilities makes India — and manufacturers like Kilitch Drugs an ideal choice.
If you are looking for a trusted pharmaceutical contract manufacturing partner, contact Kilitch Drugs (India) Ltd today to discuss your requirements.
